Multiple Myeloma Manager

from @Point of Care

Veröffentlicht von: At Point of Care

Beschreibung

NOTE: This app now integrates with the Health app so if you choose to also manage certain heart conditions and have an Apple Watch or other device that creates heart rate data, you can now send that data to your doctor through the app giving you full control over which data you send. No health data is collected or sent from device without you specifically doing it.
Getting the Full Picture of Your Multiple Myeloma (MM)
When you are living with MM, the Multiple Myeloma Manager can help you manage the symptoms that affect you every day. Studies show that people with chronic diseases can positively affect their lives by using @Point of Care apps to track pain, medications, and more—giving a sense of control over their conditions.
For many, the best part of using Multiple Myeloma Manager, is seeing moods, pain, medications—even how often they journal—in colorful pie charts. When your health journey is presented this way, it is easier to spot trends, notice strengths, and identify areas of concern.
When You Download Multiple Myeloma Manager and Register, You Can:
• Track your progress and symptoms by filling in the daily journal with its sliders and buttons and watch your data transform into easy-to-read charts
• Manage your medications and treatments, including reminders
• Use the photo upload feature to share visible symptoms with care providers
• Connect to care providers so they can monitor your progress between visits and better understand how your condition is affecting you
• Stay up-to-date with the latest information on MM when you access the “Learn More” section
• In-app Help guides you through the features so you can get the most out of the app
• Experience the new animated feature @Points Rewards and accumulate badges by using the app
A Wealth of Medical Expertise Going Back to 1980
Our @Point of Care platform is an award-winning digital technology. It provides mobile, desktop, digital clinical answers at the point of care through Projects In Knowledge™. To be able to connect with you and share your HIPAA-protected information, tell your care provider to download our @Point of Care Suite App or register online at www.atpointofcare.com.
Ausblenden Mehr anzeigen...

Screenshots

Multiple Myeloma Manager Häufige Fragen

  • Ist Multiple Myeloma Manager kostenlos?

    Ja, Multiple Myeloma Manager ist komplett kostenlos und enthält keine In-App-Käufe oder Abonnements.

  • Ist Multiple Myeloma Manager seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet Multiple Myeloma Manager?

    Multiple Myeloma Manager ist kostenlos.

  • Wie hoch ist der Umsatz von Multiple Myeloma Manager?

    Um geschätzte Einnahmen der Multiple Myeloma Manager-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung
Die App ist in Brasilien noch nicht bewertet.
Bewertungsverlauf

Multiple Myeloma Manager Bewertungen

Keine Bewertungen in Brasilien
Die App hat noch keine Bewertungen in Brasilien.

Store-Rankings

Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
App ist noch nicht gerankt

Multiple Myeloma Manager Installationen

Letzte 30 Tage

Multiple Myeloma Manager Umsatz

Letzte 30 Tage

Multiple Myeloma Manager Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von Multiple Myeloma Manager mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.